The reproductive system of both males and females are specialized in function and that they only work with the specific gender they are given to. While the female reproductive system is more complex as it houses the environment a fertilized egg will grow into, the male reproductive system is in no way a simple one as well. Perhaps, the most visible difference of the male reproductive system to that of the females is that the male have an external protruding structure. This external structure is situated outside of the body and consists of the penis, the testicles, and the scrotum. Read more…
Use in normal-cholesterol patients is on the horizon — will over-the-counter be next?
The most frequently prescribed drug class in Canada may soon become much, much more popular.
AstraZeneca has filed an application with Health Canada to add a new indication for its drug rosuvastatin (Crestor). The application, filed late last year and still under review, asks that rosuvastatin be licensed for use in older patients with normal cholesterol levels but elevated high-sensitivity C-reactive protein (CRP). If approved, the new indication could potentially result in millions of Canadian patients being put on preventive statin therapy.
Whether or not AstraZeneca’s new application is approved, however, recent research makes it all but certain that statins are well on their way to far wider use in the years to come.
to read the rest of this article on the Parkhurst Exchange website.
Posted by David Elkins and others at 12:00 AM